Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jan 17, 2013
For more info, visit http://www.bio-rad.com/yt/5/proteonwe.... The applicability and throughput capacity of SPR-based assays are often limited by the time and expense involved in generating high-quality ligands and by difficulties in ensuring their integrity over multiple regeneration cycles. In this webinar, Dr John Kulman describes the development of a method to overcome these limitations utilizing reversible on-chip ligand capture from the complex medium of transiently transfected mammalian cells. Kulman and colleagues demonstrated the utility of this method in an SPR imaging array format using the ProteOn™ XPR36 system to determine the kinetic and thermodynamic parameters in antibody-antigen interactions, with dramatically reduced time and cost compared with traditional approaches.
Presenter: John Kulman, PhD Puget Sound Blood Center, USA
Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges.